视黄酸反应性CD8效应T细胞在富含IL-23的胃肠道GVHD组织中选择性增加
该研究探讨视黄酸(RA)反应性细胞在人胃肠道GVHD中的作用,采用免疫组化和流式细胞术分析allo-HSCT患者组织和血液。发现RARαhi单核细胞在GI-GVHD组织中增加并与严重程度和死亡率相关,RARαhi CD8效应T细胞共表达T-bet和IL-23R,在GI-GVHD而非皮肤GVHD中增加,且在血液中选择性扩增。RA主要增加同种反应性GI趋向性RARαhi CD8效应T细胞,IL-23富集条件通过增加β7整合素和减少调节性CD4 T细胞增强此效应。
要点
- RARαhi单核细胞在GI-GVHD组织中增加,与GVHD严重程度和死亡率相关
- RARαhi CD8效应T细胞共表达T-bet和IL-23R,在GI-GVHD组织和血液中选择性扩增
- RA和IL-23协同促进同种反应性GI趋向性CD8效应T细胞,该群体为潜在治疗靶点
核心结论
- 鉴定出一群RA反应性效应T细胞,具有独特表型,在人GI-GVHD中选择性扩增,是潜在的新治疗靶点。
研究设计与样本
- 研究采用传统和新型连续免疫染色及流式细胞术,检测接受allo-HSCT患者的组织和血液中的RA反应性T细胞,并表征RA对人T细胞同种反应的影响。
主要发现
- 暴露于RA后,人单核细胞RARα表达增加。
- RARαhi单核细胞在GI-GVHD组织中增加,含更多细胞RA结合蛋白,定位与组织损伤一致,并与GVHD严重程度和死亡率相关。
- 连续免疫染色证实存在RARαhi CD8 T细胞,共表达效应T细胞转录因子T-bet和IL-23特异性受体IL-23R,在GI-GVHD而非皮肤GVHD组织中增加,且在GI-GVHD患者血液中选择性扩增。
- 功能性方法显示RA主要增加同种反应性GI趋向性RARαhi CD8效应T细胞,包括体内鉴定的表型细胞。
- IL-23富集条件通过选择性增加CD8效应T细胞上β7整合素表达和减少调节性表型CD4 T细胞来增强此效应。
临床怎么用
- RA反应性RARαhi CD8效应T细胞可能作为GI-GVHD的新治疗靶点,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastrointestinal (GI) graft-versus-host disease (GVHD) is a major barrier in allogeneic hematopoietic stem cell transplantation (allo-HSCT). The metabolite retinoic acid (RA) potentiates GI-GVHD in mice via alloreactive T cells expressing the RA receptor-α (RARα), but the role of RA-responsive cells in human GI-GVHD remains undefined. Therefore, we used conventional and novel sequential immunostaining and flow cytometry to scrutinize RA-responsive T cells in tissues and blood of patients who had received allo-HSCT and to characterize the impact of RA on human T-cell alloresponses. Expression of RARα by human mononuclear cells was increased after exposure to RA. RARαhi mononuclear cells were increased in GI-GVHD tissue, contained more cellular RA-binding proteins, localized with tissue damage, and correlated with GVHD severity and mortality. By using a targeted candidate protein approach, we predicted the phenotype of RA-responsive T cells in the context of increased microenvironmental interleukin-23 (IL-23). Sequential immunostaining confirmed the presence of a population of RARαhi CD8 T cells with the predicted phenotype that coexpressed the effector T-cell transcription factor T-bet and the IL-23-specific receptor (IL-23R). These cells were increased in GI- but not skin-GVHD tissues and were also selectively expanded in the blood of patients with GI-GVHD. Finally, functional approaches demonstrated that RA predominantly increased alloreactive GI-tropic RARαhi CD8 effector T cells, including cells with the phenotype identified in vivo. IL-23-rich conditions potentiated this effect by selectively increasing β7 integrin expression on CD8 effector T cells and reducing CD4 T cells with a regulatory cell phenotype. In summary, we have identified a population of RA-responsive effector T cells with a distinctive phenotype that is selectively expanded in human GI-GVHD and that represents a potential new therapeutic target.
引用
- Ball JA, Clear A, Aries J, et al. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD. Blood. 2021. PMID: 32905596. doi:10.1182/blood.2020005170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。